Home > Healthcare > Pharmaceuticals > Finished Drug Form > Sodium Hyaluronate-based Products Market

Sodium Hyaluronate-based Products Market Analysis

  • Report ID: GMI8374
  • Published Date: Mar 2024
  • Report Format: PDF

Sodium Hyaluronate-based Products Market Analysis

The market by product is categorized into injectable, topical, and other products. The injectable segment garnered USD 9.7 billion revenue in 2023.
 

  • There's a growing demand for cosmetic procedures to cure aging symptoms including wrinkles, volume loss, and face sagging as the global population grows older. Injectable sodium hyaluronate-based dermal fillers are a non-surgical option for individuals seeking to restore face volume, smooth wrinkles, and achieve a more youthful appearance.
     
  • Furthermore, injectable sodium hyaluronate-based fillers are considered minimally invasive procedures compared to surgical interventions, appealing to individuals seeking cosmetic enhancements with minimal downtime and recovery. The convenience, safety, and relatively low risk associated with dermal fillers contribute to their popularity among patients and healthcare providers alike.
     
Sodium Hyaluronate-based Products Market, By Application (2023)

Based on application, the sodium hyaluronate-based products market is segmented into pharmaceuticals, and cosmetics. The pharmaceuticals segment is further bifurcated into ophthalmology, orthopedic, dermatology, urology, and other pharmaceuticals. The pharmaceuticals segment accounted for over 69% business share in 2023 and is anticipated to witness highest growth.
 

  • The prevalence of ophthalmic diseases such as dry eye syndrome, cataracts, and ocular surface diseases is on the rise, owing to the factors such as aging populations, environmental contaminants, and digital gadget use. Sodium hyaluronate-based ophthalmic treatments lubricate, hydrate, and protect the ocular surface, relieving dry eyes and other ocular diseases. For instance, according to the American Academy of Ophthalmology, approximately 2.5 million eye injuries occur in the U.S. annually.
     
  • Moreover, pharmaceutical-grade sodium hyaluronate is a key ingredient in dermal fillers, wound dressings, and medical devices used in dermatology and wound care. Injectable dermal fillers containing hyaluronic acid are utilized for facial augmentation, scar revision, and soft tissue contouring, while hyaluronate-based wound dressings promote wound healing, tissue regeneration, and moisture management in acute and chronic wounds, thereby fostering segmental growth in the market.
     

The sodium hyaluronate-based products market by end-use is categorized into hospitals, ambulatory surgical centers, and other end-users. The hospitals segment accounted for around USD 6.6 billion revenue size in 2023.
 

  • Hospitals are primary settings for various surgical procedures and medical interventions where sodium hyaluronate-based products are utilized. In ophthalmology, sodium hyaluronate is used in intraocular surgeries such as cataract extraction and intraocular lens implantation, where ophthalmic viscosurgical devices (OVDs) help maintain intraocular pressure and protect delicate ocular tissues.
     
  • Additionally, hospitals provide comprehensive post-surgical care and wound management services, where sodium hyaluronate-based dressings and gels are employed to promote wound healing, tissue regeneration, and moisture retention. Hyaluronic acid-based wound care products create a moist environment conducive to healing, minimize scarring, and reduce the risk of infection in acute and chronic wounds.
     
North America Sodium Hyaluronate-based Products Market, 2020 – 2032 (USD Billion)

North America sodium hyaluronate-based products market accounted for USD 4.5 billion revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

  • North America boasts a thriving skincare and cosmetic industry, characterized by product innovation, technological advancements, and consumer-driven trends. Sodium hyaluronate is a key ingredient in many skincare and cosmetic formulations, including moisturizers, serums, masks, and dermal fillers, catering to diverse consumer preferences and aesthetic needs.
     
  • Furthermore, non-invasive aesthetic treatments, including injectable dermal fillers and minimally invasive procedures, are increasingly popular in the region, driven by factors such as convenience, minimal downtime, and natural-looking results. Sodium hyaluronate-based dermal fillers offer safe, effective, and customizable solutions for patients seeking facial rejuvenation, volume enhancement, and contouring without undergoing surgical procedures, leading to the regional growth.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global sodium hyaluronate-based products industry size was valued at USD 11.3 billion in 2023 and is estimated to reach over USD 22.7 billion by 2032, attributed to various factors, including the ongoing advancements in formulation technologies, and rising demand for anti-aging products.

Injectable sodium hyaluronate-based products industry garnered USD 9.7 billion in revenue in 2023 and is set to grow rapidly by 2032, owing to their convenience, safety, and relatively low risk.

North America sodium hyaluronate-based products industry size was USD 4.5 billion in 2023 and is predicted to witness substantial growth till 2032 driven by the thriving skincare & cosmetic sector, characterized by product innovation, technological advancements, and consumer-driven trends.

ASHLAND INC., Allergan, Inc., Anika Therapeutics, Inc, Bohus BioTech AB, Cadila Pharmaceuticals, Ferring B.V., Fidia Farmaceutici S.p.A., GALDERMA, LG Chem, Ltd., Syner-Med (Pharmaceutical Products) Ltd. are some of the major industry contenders.

Sodium Hyaluronate-based Products Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 261
  • Countries covered: 22
  • Pages: 110
 Download Free Sample